Douglas Berger Psychiatrist Tokyo

Douglas Berger psychiatrist Tokyo is an American board certified psychiatrist and is the Director of the Tokyo Meguro Counseling Center. He’s also fully bilingual in Japanese and English. Dr. Berger received his M.D. and psychiatry training from New York Medical College, and his Ph.D. from the Department of Psychosomatic Medicine at the Tokyo University School of Medicine. He speaks native-level Japanese. Dr. Berger utilizes a variety of approaches to psychiatry, which you can find here, and on the Tokyo Meguro Counseling Center’s home page.

Dr. Berger can be contacted by phone: 03-3716-6624 (+81-3-3716-6624 from outside of Japan). Please use this form if you wish to contact Dr. Douglas Berger psychiatrist in Tokyo.

> Dr. Berger’s credentials & publications can be found on this page.
> Click here for more information about his practice
> To read reviews from some of Dr. Berger’s patients.

Marijuana medicinal products are very different from smoking pot-which cannot be good for psychiatric disorders: https://t.co/Sm1B473teN Author Moss has stock in GW Pharma, makers of marijuana derivative drugs. https://t.co/K6iHnNBhQ1

Some mistakenly think tramadol is a combination drug with both an opioid and an SNRI: https://t.co/kYtNeXyy9x Tramadol has a dual mechanism of action but it is not a combination drug. https://t.co/vhEwPF9JpC

Farah’s book on Hemingway had no interview & he/his estate gave no consent https://t.co/7y5FAs4cvY There's no brain scan/autopsy. Farah does not prove chronic traumatic encephalopathy nor disprove bipolar disorder. The estate may sue after sales grow. https://t.co/1HKbrH9Y6i #li

NIDA instills pot fear in doctors as causing schizophrenia & statements like "use and possession of cannabis is illegal in under federal law" etc: https://t.co/9LKyC7PDrw. Dr. Kosten is NIDA-sponsored & Psychiatric Times known to publish NIDA articles. https://t.co/vhEwPF9JpC #li

Questionable ethics when psychiatrists label persons they did not examine, here deceased poet Robert Lowell: https://t.co/KsJ2H0XRZE Psychiatric conditions are not provable so that (re)labeling Mr. Lowell is concerning even if his doctors did so. https://t.co/RZFx8zOZJO #li

Blue-blocking glasses for mania? https://t.co/vmAOFTUtGb only 11-12 subjects in each group in a single blind (not double-blind) study, only followed for one week. Poorly controlled studies should not have results exaggerated. https://t.co/lABkWI4nXZ

Depression studies have subjective endpoints so that double blind/blind placebo are needed for efficacy: https://t.co/4XySe7dNmt Hope makes all improve on non-inferiority. "Blind assessments" are deceptive as all the subjects and treaters are UNblind. https://t.co/K6iHnNBhQ1

This study https://t.co/1mfQHq3VWs quoted the parents of a 6 year-old who heard their child's voice. They concluded “The voice and image kept him alive" though It could also be a neurological echo of an emotional memory. Psychodynamics are conjecture. https://t.co/RZFx8zOZJO

Load More...

ADHD is both over- and under-diagnosed, depending on the set of people you look at: https://t.co/wNPdlFMiUd The authors’ title “Are We Overdiagnosing and Overtreating ADHD?”, is somewhat unfair to the cohort of persons who are underdiagnosed. https://t.co/sJUSXfRv1G

Cold water swimming for depression https://t.co/rBHqTJW7bF What % and which depressives might benefit, is there placebo effect, what temp, duration, frequency is best is still unclear, & if this is reducing inflammation or stress response is conjecture. https://t.co/2opApRuwKL

There is confusion in depression with “full-remission” (no-symptoms), “effective” (defined at each use), and "responsive" (50% improvement) https://t.co/8g5BXeBjET Many trials claim efficacy using "responsive" but "responsive" is easy to achieve. Us: https://t.co/uZEIPRxr0J

Is there a list of CBT clinical trials for anxiety or depressive disorders that have had subject blinding or subject+treater blinding, or blind placebo? Rater blinding (often mistakenly called single-blind) is not so valuable as blind raters just record what the subject reports.

Funding longer GP consults seems ineffective for patients who are dead-set to get antibiotics. Funding public ads campaign, removing prescription repeats, and reducing prescription expiry to between 2 weeks and 3 months as noted in the article seems the way to go.

While antidepressant efficacy in a clinical trial may vary, drug trials are double blind w/blind placebo control vs. psychotherapy trials which can not have patient or therapist blinding nor blind placebo & have high bias risk. https://t.co/8g5BXeBjET. https://t.co/2rZk8Z6wvc

Gut Microbes in Psychosis: https://t.co/qgrw7arZfh & https://t.co/zmpp9c0XXK -Only 28 subjects/15 controls, ad hoc search for effect of 7 microbe types suggests false-positives because of multiple chances of having some microbes w/effect. P value needs to be halved for each test.

Psychogenic Purpura: strange interface between mind and body https://t.co/dJZM8GHAKG. We should be modest in concluding psychopathology in these persons and change the "psychogenic" term to "idiopathic". https://t.co/5aZe9SJbH4

Load More...

Save

Save